Robert E. Molokie

Effects of 5-aza-2′-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease

Yogen Saunthararajah, Cheryl A. Hillery, Don Lavelle et al. · Blood · 2003 · 282 citations · Full text

Medicine, Hematology, Molecular Medicine +14

2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia

Mabel Koshy, Louise Dorn, Linda R. Bressler et al. · Blood · 2000 · 174 citations

Medicine, Hematology, Molecular Medicine +9

Patient-Reported Outcomes: Descriptors of Nociceptive and Neuropathic Pain and Barriers to Effective Pain Management in Adult Outpatients With Sickle Cell Disease

Diana J. Wilkie, Robert E. Molokie, Debra Boyd-Seal et al. · Journal of the National Medical Association · 2010 · 173 citations · Full text

Medicine, Internal Medicine, Outcomes Research +16

Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease

Santosh L. Saraf, Annie Oh, Pritesh Patel et al. · Biology of Blood and Marrow Transplantation · 2015 · 147 citations · Full text

Medicine, Hematology, Immunology +17

Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study

Robert E. Molokie, Donald Lavelle, Michel Gowhari et al. · PLoS Medicine · 2017 · 146 citations · Full text

Medicine, Hematology, Pharmacology +12